Home / About Barrow Neurological Institute / News & Articles / Uncategorized / Amylyx Pharmaceuticals Announces Publication of Data Showing the Effect of AMX0035 on Plasma Neuroinflammatory Biomarkers in ALS Amylyx Pharmaceuticals Announces Publication of Data Showing the Effect of AMX0035 on Plasma Neuroinflammatory Biomarkers in ALS Byline: Andrew Wachtel December 5, 2023 Uncategorized FacebookTweetLinkedIn
Amylyx Pharmaceuticals Announces Publication of Data Showing the Effect of AMX0035 on Plasma Neuroinflammatory Biomarkers in ALS Byline: Andrew Wachtel December 5, 2023 Uncategorized FacebookTweetLinkedIn